Skip to content

Clinical trials

Observational Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Observational Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20051
20063
20071
20082
20107
20113
20134
20143
20161
20173
20184
20193
202012
202114
202212
202311
20248
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Unknown status28
Recruiting24
Active, not recruiting10
Not yet recruiting7
Terminated3
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
National Human Genome Research Institute (NHGRI)4
National Jewish Health4
Boehringer Ingelheim3
Erasmus Medical Center3
Pulmonary Care and Research Collaborative Limited3
Assiut University2
Fondazione IRCCS Policlinico San Matteo di Pavia2
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2
Hospital do Coracao2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis120
Lung Diseases, Interstitial38
Idiopathic Pulmonary Fibrosis21
Pulmonary Disease, Chronic Obstructive11
Lung Diseases10
Sarcoidosis9
COVID-197
Arthritis, Rheumatoid6
Asthma6
Cystic Fibrosis6

Trials

Showing 26 to 50 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.